CCR5 is involved in proliferation and migration of melanoma cells in vitro and supports the mesenchymal phenotype of metastatic melanoma cells by increasing TGF-β1, which in turn induces EMT and migration via PI3K/AKT/GSK3β signaling [50]. The gene discussed is GSK3B; the disease is melanoma.